NEW YORK, March 2 (GenomeWeb News) - Spectral Genomics of Houston, Texas, said yesterday that it has agreed to license certain Affymetrix patents to manufacture and sell spotted DNA arrays for use in the diagnostics market.

The agreement will commence "once the necessary regulatory approvals of Spectral Genomics' products have been obtained," the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.